Table of Contents Executive Summary 1 Industry Overview of Irritable Bowel Syndrome (IBS) Therapeutics 1.1 Definition of Irritable Bowel Syndrome (IBS) Therapeutics 1.2 Irritable Bowel Syndrome (IBS) Therapeutics Segment by Type 1.2.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Production Growth Rate Comparison by Types (2014-2025) 1.2.2 Blautix (Strain) 1.2.3 Bekinda (IBS-D) 1.2.4 SYN-010 1.2.5 Tenapanor 1.3 Irritable Bowel Syndrome (IBS) Therapeutics Segment by Applications 1.3.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Consumption Comparison by Applications (2014-2025) 1.3.2 Hospital 1.3.3 Research 1.4 Global Irritable Bowel Syndrome (IBS) Therapeutics Overall Market 1.4.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue (2014-2025) 1.4.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Production (2014-2025) 1.4.3 North America Irritable Bowel Syndrome (IBS) Therapeutics Status and Prospect (2014-2025) 1.4.4 Europe Irritable Bowel Syndrome (IBS) Therapeutics Status and Prospect (2014-2025) 1.4.5 China Irritable Bowel Syndrome (IBS) Therapeutics Status and Prospect (2014-2025) 1.4.6 Japan Irritable Bowel Syndrome (IBS) Therapeutics Status and Prospect (2014-2025) 1.4.7 Southeast Asia Irritable Bowel Syndrome (IBS) Therapeutics Status and Prospect (2014-2025) 1.4.8 India Irritable Bowel Syndrome (IBS) Therapeutics Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Irritable Bowel Syndrome (IBS) Therapeutics 2.3 Manufacturing Process Analysis of Irritable Bowel Syndrome (IBS) Therapeutics 2.4 Industry Chain Structure of Irritable Bowel Syndrome (IBS) Therapeutics 3 Development and Manufacturing Plants Analysis of Irritable Bowel Syndrome (IBS) Therapeutics 3.1 Capacity and Commercial Production Date 3.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Irritable Bowel Syndrome (IBS) Therapeutics 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Irritable Bowel Syndrome (IBS) Therapeutics Production and Capacity Analysis 4.2 Irritable Bowel Syndrome (IBS) Therapeutics Revenue Analysis 4.3 Irritable Bowel Syndrome (IBS) Therapeutics Price Analysis 4.4 Market Concentration Degree 5 Irritable Bowel Syndrome (IBS) Therapeutics Regional Market Analysis 5.1 Irritable Bowel Syndrome (IBS) Therapeutics Production by Regions 5.1.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Production by Regions 5.1.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Regions 5.2 Irritable Bowel Syndrome (IBS) Therapeutics Consumption by Regions 5.3 North America Irritable Bowel Syndrome (IBS) Therapeutics Market Analysis 5.3.1 North America Irritable Bowel Syndrome (IBS) Therapeutics Production 5.3.2 North America Irritable Bowel Syndrome (IBS) Therapeutics Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Irritable Bowel Syndrome (IBS) Therapeutics Import and Export 5.4 Europe Irritable Bowel Syndrome (IBS) Therapeutics Market Analysis 5.4.1 Europe Irritable Bowel Syndrome (IBS) Therapeutics Production 5.4.2 Europe Irritable Bowel Syndrome (IBS) Therapeutics Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Irritable Bowel Syndrome (IBS) Therapeutics Import and Export 5.5 China Irritable Bowel Syndrome (IBS) Therapeutics Market Analysis 5.5.1 China Irritable Bowel Syndrome (IBS) Therapeutics Production 5.5.2 China Irritable Bowel Syndrome (IBS) Therapeutics Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Irritable Bowel Syndrome (IBS) Therapeutics Import and Export 5.6 Japan Irritable Bowel Syndrome (IBS) Therapeutics Market Analysis 5.6.1 Japan Irritable Bowel Syndrome (IBS) Therapeutics Production 5.6.2 Japan Irritable Bowel Syndrome (IBS) Therapeutics Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Irritable Bowel Syndrome (IBS) Therapeutics Import and Export 5.7 Southeast Asia Irritable Bowel Syndrome (IBS) Therapeutics Market Analysis 5.7.1 Southeast Asia Irritable Bowel Syndrome (IBS) Therapeutics Production 5.7.2 Southeast Asia Irritable Bowel Syndrome (IBS) Therapeutics Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Irritable Bowel Syndrome (IBS) Therapeutics Import and Export 5.8 India Irritable Bowel Syndrome (IBS) Therapeutics Market Analysis 5.8.1 India Irritable Bowel Syndrome (IBS) Therapeutics Production 5.8.2 India Irritable Bowel Syndrome (IBS) Therapeutics Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Irritable Bowel Syndrome (IBS) Therapeutics Import and Export 6 Irritable Bowel Syndrome (IBS) Therapeutics Segment Market Analysis (by Type) 6.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Production by Type 6.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Type 6.3 Irritable Bowel Syndrome (IBS) Therapeutics Price by Type 7 Irritable Bowel Syndrome (IBS) Therapeutics Segment Market Analysis (by Application) 7.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Consumption by Application 7.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Consumption Market Share by Application (2014-2019) 8 Irritable Bowel Syndrome (IBS) Therapeutics Major Manufacturers Analysis 8.1 Abbott Laboratories 8.1.1 Abbott Laboratories Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served 8.1.2 Abbott Laboratories Product Introduction, Application and Specification 8.1.3 Abbott Laboratories Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 Synergy Pharmaceuticals 8.2.1 Synergy Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served 8.2.2 Synergy Pharmaceuticals Product Introduction, Application and Specification 8.2.3 Synergy Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 Sucampo Pharmaceuticals 8.3.1 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served 8.3.2 Sucampo Pharmaceuticals Product Introduction, Application and Specification 8.3.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 Valeant Pharmaceuticals International 8.4.1 Valeant Pharmaceuticals International Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served 8.4.2 Valeant Pharmaceuticals International Product Introduction, Application and Specification 8.4.3 Valeant Pharmaceuticals International Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 8.5 Ardelyx 8.5.1 Ardelyx Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served 8.5.2 Ardelyx Product Introduction, Application and Specification 8.5.3 Ardelyx Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.5.4 Main Business and Markets Served 8.6 Astellas Pharma 8.6.1 Astellas Pharma Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served 8.6.2 Astellas Pharma Product Introduction, Application and Specification 8.6.3 Astellas Pharma Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.6.4 Main Business and Markets Served 8.7 Novartis 8.7.1 Novartis Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served 8.7.2 Novartis Product Introduction, Application and Specification 8.7.3 Novartis Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.7.4 Main Business and Markets Served 8.8 GlaxoSmithKline 8.8.1 GlaxoSmithKline Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served 8.8.2 GlaxoSmithKline Product Introduction, Application and Specification 8.8.3 GlaxoSmithKline Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.8.4 Main Business and Markets Served 8.9 Ironwood Pharmaceuticals 8.9.1 Ironwood Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served 8.9.2 Ironwood Pharmaceuticals Product Introduction, Application and Specification 8.9.3 Ironwood Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.9.4 Main Business and Markets Served 9 Development Trend of Analysis of Irritable Bowel Syndrome (IBS) Therapeutics Market 9.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Market Trend Analysis 9.1.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Market Size (Volume and Value) Forecast 2019-2025 9.2 Irritable Bowel Syndrome (IBS) Therapeutics Regional Market Trend 9.2.1 North America Irritable Bowel Syndrome (IBS) Therapeutics Forecast 2019-2025 9.2.2 Europe Irritable Bowel Syndrome (IBS) Therapeutics Forecast 2019-2025 9.2.3 China Irritable Bowel Syndrome (IBS) Therapeutics Forecast 2019-2025 9.2.4 Japan Irritable Bowel Syndrome (IBS) Therapeutics Forecast 2019-2025 9.2.5 Southeast Asia Irritable Bowel Syndrome (IBS) Therapeutics Forecast 2019-2025 9.2.6 India Irritable Bowel Syndrome (IBS) Therapeutics Forecast 2019-2025 9.3 Irritable Bowel Syndrome (IBS) Therapeutics Market Trend (Product Type) 9.4 Irritable Bowel Syndrome (IBS) Therapeutics Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Irritable Bowel Syndrome (IBS) Therapeutics Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of Irritable Bowel Syndrome (IBS) Therapeutics Table Global Irritable Bowel Syndrome (IBS) Therapeutics Production (K Units) Growth Rate Comparison by Types (2014-2025) Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Production Market Share by Types in 2018 Figure Blautix (Strain) Product Picture Figure Bekinda (IBS-D) Product Picture Figure SYN-010 Product Picture Figure Tenapanor Product Picture Table Global Irritable Bowel Syndrome (IBS) Therapeutics Consumption (K Units) Comparison by Applications (2014-2025) Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Consumption Market Share by Applications in 2018 Figure Hospital Figure Research Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue (Million USD) (2014-2025) Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Production (K Units) (2014-2025) Figure North America Irritable Bowel Syndrome (IBS) Therapeutics Market Size (Million USD) (2014-2025) Figure Europe Irritable Bowel Syndrome (IBS) Therapeutics Market Size (Million USD) (2014-2025) Figure China Irritable Bowel Syndrome (IBS) Therapeutics Market Size (Million USD) (2014-2025) Figure Japan Irritable Bowel Syndrome (IBS) Therapeutics Market Size (Million USD) (2014-2025) Figure Southeast Asia Irritable Bowel Syndrome (IBS) Therapeutics Market Size (Million USD) (2014-2025) Figure India Irritable Bowel Syndrome (IBS) Therapeutics Market Size (Million USD) (2014-2025) Table Irritable Bowel Syndrome (IBS) Therapeutics Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Irritable Bowel Syndrome (IBS) Therapeutics in 2018 Figure Manufacturing Process Analysis of Irritable Bowel Syndrome (IBS) Therapeutics Figure Industry Chain Structure of Irritable Bowel Syndrome (IBS) Therapeutics Table Capacity and Commercial Production Date of Key Manufacturers Table Global Irritable Bowel Syndrome (IBS) Therapeutics Manufacturing Plants Distribution Table Irritable Bowel Syndrome (IBS) Therapeutics Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table Irritable Bowel Syndrome (IBS) Therapeutics Capacity (K Units) of Major Manufacturers (2014-2019) Table Irritable Bowel Syndrome (IBS) Therapeutics Production (K Units) of Major Manufacturers (2014-2019) Table Irritable Bowel Syndrome (IBS) Therapeutics Production Market Share of Major Manufacturers (2014-2019) Figure Irritable Bowel Syndrome (IBS) Therapeutics Production Share by Manufacturers in 2018 Table Irritable Bowel Syndrome (IBS) Therapeutics Revenue (Million US$) of Major Manufacturers (2014-2019) Table Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share of Major Manufacturers (2014-2019) Figure Irritable Bowel Syndrome (IBS) Therapeutics Revenue Share by Manufacturers in 2018 Table Irritable Bowel Syndrome (IBS) Therapeutics Average Price (USD/Unit) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global Irritable Bowel Syndrome (IBS) Therapeutics Production by Regions 2014-2019 (K Units) Table Global Irritable Bowel Syndrome (IBS) Therapeutics Production Market Share by Regions 2014-2019 Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Production Market Share by Regions in 2018 Table Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Regions 2014-2019 (Million USD) Table Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Regions 2014-2019 Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Regions in 2018 Table Global Irritable Bowel Syndrome (IBS) Therapeutics Consumption by Regions 2014-2019 (K Units) Table Global Irritable Bowel Syndrome (IBS) Therapeutics Consumption Market Share by Regions 2014-2019 Figure North America Irritable Bowel Syndrome (IBS) Therapeutics Production Growth Rate 2014-2019 (K Units) Figure North America Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate 2014-2019 (Million USD) Table North America Irritable Bowel Syndrome (IBS) Therapeutics Production, Consumption Import and Export (K Units) Figure Europe Irritable Bowel Syndrome (IBS) Therapeutics Production Growth Rate 2014-2019 (K Units) Figure Europe Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate 2014-2019 (Million USD) Table Europe Irritable Bowel Syndrome (IBS) Therapeutics Production, Consumption Import and Export (K Units) Figure China Irritable Bowel Syndrome (IBS) Therapeutics Production Growth Rate 2014-2019 (K Units) Figure China Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate 2014-2019 (Million USD) Table China Irritable Bowel Syndrome (IBS) Therapeutics Production, Consumption Import and Export (K Units) Figure Japan Irritable Bowel Syndrome (IBS) Therapeutics Production Growth Rate 2014-2019 (K Units) Figure Japan Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate 2014-2019 (Million USD) Table Japan Irritable Bowel Syndrome (IBS) Therapeutics Production, Consumption Import and Export (K Units) Figure Southeast Asia Irritable Bowel Syndrome (IBS) Therapeutics Production Growth Rate 2014-2019 (K Units) Figure Southeast Asia Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia Irritable Bowel Syndrome (IBS) Therapeutics Production, Consumption Import and Export (K Units) Figure India Irritable Bowel Syndrome (IBS) Therapeutics Production Growth Rate 2014-2019 (K Units) Figure India Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate 2014-2019 (Million USD) Table India Irritable Bowel Syndrome (IBS) Therapeutics Production, Consumption Import and Export (K Units) Figure Global Consumption Irritable Bowel Syndrome (IBS) Therapeutics Market Share by Application (2014-2019) Figure Global Value (Consumption) Irritable Bowel Syndrome (IBS) Therapeutics Market Share by Application (2014-2019) Table Abbott Laboratories Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served Table Abbott Laboratories Irritable Bowel Syndrome (IBS) Therapeutics Product Introduction, Application and Specification Table Abbott Laboratories Irritable Bowel Syndrome (IBS) Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Abbott Laboratories Irritable Bowel Syndrome (IBS) Therapeutics Production Growth Rate (2014-2019) Table Abbott Laboratories Irritable Bowel Syndrome (IBS) Therapeutics Production Market Share (2014-2019) Figure Abbott Laboratories Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share (2014-2019) Table Abbott Laboratories Irritable Bowel Syndrome (IBS) Therapeutics Main Business and Markets Served Table Synergy Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served Table Synergy Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Product Introduction, Application and Specification Table Synergy Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Synergy Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Production Growth Rate (2014-2019) Table Synergy Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Production Market Share (2014-2019) Figure Synergy Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share (2014-2019) Table Synergy Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Main Business and Markets Served Table Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served Table Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Product Introduction, Application and Specification Table Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Production Growth Rate (2014-2019) Table Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Production Market Share (2014-2019) Figure Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share (2014-2019) Table Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Main Business and Markets Served Table Valeant Pharmaceuticals International Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served Table Valeant Pharmaceuticals International Irritable Bowel Syndrome (IBS) Therapeutics Product Introduction, Application and Specification Table Valeant Pharmaceuticals International Irritable Bowel Syndrome (IBS) Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Valeant Pharmaceuticals International Irritable Bowel Syndrome (IBS) Therapeutics Production Growth Rate (2014-2019) Table Valeant Pharmaceuticals International Irritable Bowel Syndrome (IBS) Therapeutics Production Market Share (2014-2019) Figure Valeant Pharmaceuticals International Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share (2014-2019) Table Valeant Pharmaceuticals International Irritable Bowel Syndrome (IBS) Therapeutics Main Business and Markets Served Table Ardelyx Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served Table Ardelyx Irritable Bowel Syndrome (IBS) Therapeutics Product Introduction, Application and Specification Table Ardelyx Irritable Bowel Syndrome (IBS) Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Ardelyx Irritable Bowel Syndrome (IBS) Therapeutics Production Growth Rate (2014-2019) Table Ardelyx Irritable Bowel Syndrome (IBS) Therapeutics Production Market Share (2014-2019) Figure Ardelyx Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share (2014-2019) Table Ardelyx Irritable Bowel Syndrome (IBS) Therapeutics Main Business and Markets Served Table Astellas Pharma Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served Table Astellas Pharma Irritable Bowel Syndrome (IBS) Therapeutics Product Introduction, Application and Specification Table Astellas Pharma Irritable Bowel Syndrome (IBS) Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Astellas Pharma Irritable Bowel Syndrome (IBS) Therapeutics Production Growth Rate (2014-2019) Table Astellas Pharma Irritable Bowel Syndrome (IBS) Therapeutics Production Market Share (2014-2019) Figure Astellas Pharma Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share (2014-2019) Table Astellas Pharma Irritable Bowel Syndrome (IBS) Therapeutics Main Business and Markets Served Table Novartis Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served Table Novartis Irritable Bowel Syndrome (IBS) Therapeutics Product Introduction, Application and Specification Table Novartis Irritable Bowel Syndrome (IBS) Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Novartis Irritable Bowel Syndrome (IBS) Therapeutics Production Growth Rate (2014-2019) Table Novartis Irritable Bowel Syndrome (IBS) Therapeutics Production Market Share (2014-2019) Figure Novartis Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share (2014-2019) Table Novartis Irritable Bowel Syndrome (IBS) Therapeutics Main Business and Markets Served Table GlaxoSmithKline Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served Table GlaxoSmithKline Irritable Bowel Syndrome (IBS) Therapeutics Product Introduction, Application and Specification Table GlaxoSmithKline Irritable Bowel Syndrome (IBS) Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table GlaxoSmithKline Irritable Bowel Syndrome (IBS) Therapeutics Production Growth Rate (2014-2019) Table GlaxoSmithKline Irritable Bowel Syndrome (IBS) Therapeutics Production Market Share (2014-2019) Figure GlaxoSmithKline Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share (2014-2019) Table GlaxoSmithKline Irritable Bowel Syndrome (IBS) Therapeutics Main Business and Markets Served Table Ironwood Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served Table Ironwood Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Product Introduction, Application and Specification Table Ironwood Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Ironwood Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Production Growth Rate (2014-2019) Table Ironwood Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Production Market Share (2014-2019) Figure Ironwood Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share (2014-2019) Table Ironwood Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Main Business and Markets Served Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Production (K Units) Growth Rate Forecast 2019-2025 Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Price (USD/Unit) Forecast 2019-2025 Figure North America Irritable Bowel Syndrome (IBS) Therapeutics Production Growth Rate Forecast 2019-2025 (K Units) Figure North America Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe Irritable Bowel Syndrome (IBS) Therapeutics Production Growth Rate Forecast 2019-2025 (K Units) Figure Europe Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China Irritable Bowel Syndrome (IBS) Therapeutics Production Growth Rate Forecast 2019-2025 (K Units) Figure China Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan Irritable Bowel Syndrome (IBS) Therapeutics Production Growth Rate Forecast 2019-2025 (K Units) Figure Japan Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia Irritable Bowel Syndrome (IBS) Therapeutics Production Growth Rate Forecast 2019-2025 (K Units) Figure Southeast Asia Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India Irritable Bowel Syndrome (IBS) Therapeutics Production Growth Rate Forecast 2019-2025 (K Units) Figure India Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (K Units) of Irritable Bowel Syndrome (IBS) Therapeutics by Type (2019-2025) Table Global Consumption (K Units) of Irritable Bowel Syndrome (IBS) Therapeutics by Application (2019-2025) Table Irritable Bowel Syndrome (IBS) Therapeutics Distributors List Table Irritable Bowel Syndrome (IBS) Therapeutics Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Abbott Laboratories Synergy Pharmaceuticals Sucampo Pharmaceuticals Valeant Pharmaceuticals International Ardelyx Astellas Pharma Novartis GlaxoSmithKline Ironwood Pharmaceuticals